Form 8-K - Current report:
SEC Accession No. 0001654954-20-006146
Filing Date
2020-06-01
Accepted
2020-06-01 08:02:08
Documents
18
Period of Report
2020-06-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ndra_8k.htm 8-K 26176
2 INVESTOR PRESENTATION DATED JUNE 2020 ISSUED BY THE COMPANY, FURNISHED HEREWITH. ndra_ex991.htm EX-99.1 14001
3 IMAGE ndra_ex991000.jpg GRAPHIC 56485
4 IMAGE ndra_ex991001.jpg GRAPHIC 141377
5 IMAGE ndra_ex991002.jpg GRAPHIC 98619
6 IMAGE ndra_ex991003.jpg GRAPHIC 120563
7 IMAGE ndra_ex991004.jpg GRAPHIC 92422
8 IMAGE ndra_ex991005.jpg GRAPHIC 120893
9 IMAGE ndra_ex991006.jpg GRAPHIC 104429
10 IMAGE ndra_ex991007.jpg GRAPHIC 112928
11 IMAGE ndra_ex991008.jpg GRAPHIC 96530
12 IMAGE ndra_ex991009.jpg GRAPHIC 102551
13 IMAGE ndra_ex991010.jpg GRAPHIC 131769
14 IMAGE ndra_ex991011.jpg GRAPHIC 107440
15 IMAGE ndra_ex991012.jpg GRAPHIC 99570
16 IMAGE ndra_ex991013.jpg GRAPHIC 72535
17 IMAGE ndra_ex991014.jpg GRAPHIC 94849
18 IMAGE ndra_ex991slide1.jpg GRAPHIC 160059
  Complete submission text file 0001654954-20-006146.txt   2402072
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 20930972
SIC: 3845 Electromedical & Electrotherapeutic Apparatus